As filed with the Securities and Exchange Commission on July 27, 2004

===============================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
              ----------------------------------------------------
                                    FORM S-8

                             REGISTRATION STATEMENT
                                      under
                           THE SECURITIES ACT OF 1933
              ----------------------------------------------------

                          UNITED STATES ANTIMONY CORP.
             (Exact name of registrant as specified in its charter)

                                     Montana
         (State or other jurisdiction of incorporation or organization)

                                   81-0305822
                      (IRS Employer Identification Number)

                                  P.O. Box 643
                          Thompson Falls, Montana 59873
                    (Address of principal executive offices)

                           John C. Lawrence, President
                          United States Antimony Corp.
                                  P.O. Box 643
                          Thompson Falls, Montana 59873
                     (Name and address of agent for service)

                                 (406) 827-3523
          (Telephone number, including area code of agent for service)

                    2004 Directors, Officers and Consultants
                Stock Option, Stock Warrant and Stock Award Plan
                            (Full title of the Plans)
          -------------------------------------------------------------

                         CALCULATION OF REGISTRATION FEE

------------------------- ---------------------- ----------------------- ---------------------- ----------------------
                                                                                    
                                                    Proposed maximum       Proposed maximum
 Title of securities to       Amount to be         offering price per     aggregate offering          Amount of
     be registered            Registered(1)             share(3)               price(3)          registration fee(2)
------------------------- ---------------------- ----------------------- ---------------------- ----------------------

Common Stock,
  $.001 par value                400,000                 $0.31               $124,000.00               $15.71
                          ----------------------                                                ----------------------
          TOTAL                  400,000                                                               $15.71
------------------------- ---------------------- ---------------------- ----------------------- ----------------------

(1)      Includes such indeterminate number of shares of Common Stock of the
         Registrant as may be issuable by reason of the
         anti-dilution provisions of the Plan.
(2)      Pursuant to Rule 457(h) under the Securities Act of 1933, as amended,
         the registration fee was computed on the basis of the market value of
         the shares of Common Stock to be registered hereby estimated in
         accordance with Rule 457(c), solely for the purpose of computing the
         registration fee, on the basis of the average of the high and low sales
         prices per share of Common Stock of the Registrant on July 27, 2004.
(3)      The offering price is based upon the exercise price of the warrants
         pursuant to Rule 457(f)(2).


                                     PART I

         The documents containing the information specified in this Part I will
be sent or given to participants in the 2004 Directors, Officers and Consultants
Stock Option, Stock Warrant and Stock Award Plan(the "Plan) as specified by Rule
428(b)(1). Pursuant to the instructions for Form S-8, such documents need not be
filed with the Commission either as part of the Registration Statement or as
prospectuses or prospectus supplements pursuant to Rule 424. These documents and
the documents incorporated by reference in this Registration Statement pursuant
to Item 3 of Part II of this Registration Statement, taken together, constitute
a prospectus that meets the requirements of Section 10(a) of the Securities Act
of 1933, as amended. See Rule 428(a)(1).


                                     PART II
               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

         The documents listed in (a) and (b) below have been filed by the
Registrant, United States Antimony Corp., a Montana corporation (the "Company"),
with the Securities and Exchange Commission (the "Commission") and are
incorporated by reference in this Registration Statement. All documents
subsequently filed by the Registrant pursuant to Section 13(a), 13(c), 14 and
15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"),
prior to the filing of a post-effective amendment which indicates that all
securities offered have been sold or which deregisters all securities then
remaining unsold shall be deemed to be incorporated by reference in the
Registration Statement and to be part thereof from the date of filing of such
documents.

                  (a) Form 10-KSB for the year ended December 31, 2003 and filed
         on April 12, 2004. The above referenced reports, which were previously
         filed with the Commission, are incorporated herein by reference.

                  (b) All other reports filed pursuant to Section 13 or 15(d) of
         the Exchange Act since the end of the fiscal year covered by the
         Registrant's Form 10-KSB for the period ended December 31, 2003.

         The above referenced reports, which were previously filed with the
Commission, are incorporated herein by reference.

Item 4:  Description of Securities

         Not Applicable

Item 5:  Interests of Named Experts and Counsel.

         None

Item 6:  Indemnification of Directors and Officers.

         The Bylaws ("Bylaws") of the Company provide that to the full extent
permitted by law, the Company shall indemnify and advance expenses to any person
who is or was a director or officer of the Company, or was serving at the
request of a director, officer, employee or fiduciary of the Company, against
liabilities which may be incurred by such person by reason of (or arising in
part from) such capacity. The Company shall not indemnify any director or
officer in matters in which he is adjudged to have been derelict in his duty as
an officer or director if the total expense of settlement substantially exceeds
costs of litigation to a conclusion. Further, the Company shall not indemnify an
officer or director in any action based on Section 16(b) of the Exchange Act or
similar federal or state statute wherein the officer or director is adjudged to
have breached his duty to the Company. The Company shall indemnify an officer or
director in successful defense of a suit or criminal action; and, prior to
conclusion of the suit, the Company may indemnify an officer or director's
expenses of the suit if the officer or director furnishes an undertaking to the
Company in the event it is determined that the acts of the officer or director
were unauthorized or improper.

         Section 35-1-452 of the Montana Code Annotated of 2003 ("MCA")
authorizes the indemnification of directors against liability incurred by reason
of being a director and against expenses reasonably incurred in connection with
any action, suit or proceeding seeking to establish such liability, in the case
of third-party claims, if the director acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best interest of the
corporation, and in the case of actions by or in the right of the corporation,
if the director acted in good faith and in a manner he reasonably believed to be
in or not opposed to the best interest of the corporation, unless, despite the
adjudication of liability, a court otherwise determines. Indemnification also is
authorized with respect to any criminal action or proceeding where, in addition
to the above, the director has no reasonable cause to believe that his conduct
was unlawful. Section 35-1-453 provides mandatory indemnification against
reasonable expenses of a director who is successful in the defense of any
proceeding to which he was a party because he is or was a director, unless
limited by a corporation's articles.

         Section 35-1-457 of the MCA provides for mandatory indemnification of
officers pursuant to Section 35-1-453 of the MCA, unless contrary to the
corporation's articles, and provides that officers are entitled to apply for
court-ordered indemnification to the same extent as a director pursuant to
Section 35-1-455 of the MCA, together with indemnification against reasonable
expenses.

         The above discussion of the Company's Bylaws and Sections 35-1-452,
35-1-453, 35-1-455, and 35-1-457 of the MCA is only a summary and is qualified
in its entirety by the full text of each of the foregoing.

Item 7.  Exemption From Registration Claimed.

         Not Applicable

Item 8:  Exhibits

         The following documents are filed as Exhibits to this Registration
Statement:

                  4.1      --       2004 Directors, Officers and Consultants
                                    Stock Option, Stock Warrant and Stock Award
                                    Plan

                  5        --       Opinion of Sonfield & Sonfield as to the
                                    authorization and issuance of the shares
                                    being registered.

                  24.1     --       Consent of Sonfield & Sonfield (included in
                                    Exhibit 5)

                  24.2     --       Consent of DeCoria, Maichel & Teague P.S.,
                                    Certified Public Accountant

Item 9:  Undertakings

         The undersigned registrant hereby undertakes:

(a)                        to file, during any period in which offers or sales
                           are being made, a post-effective amendment to this
                           registration statement to include any material
                           information with respect to the plan of distribution
                           not previously disclosed in the registration
                           statement or any material change to such information
                           in the registration statement;

(b)                        that, for the purpose of determining any liability
                           under the Securities Act of 1933, each such
                           post-effective amendment shall be deemed to be a new
                           registration statement relating to the securities
                           offered therein, and the offering of such securities
                           at that time shall be deemed to be the initial bona
                           fide offering thereof; and

(c)                        to remove from registration by means of a
                           post-effective amendment any of the securities being
                           registered which remain unsold at the termination of
                           the offering.



                                   SIGNATURES

         THE REGISTRANT: Pursuant to the requirements of the Securities Act of
1933, the registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8, and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Thompson Falls, Montana on the 12th day of July, 2004.

United States Antimony Corp.



By: /s/John C. Lawrence
   --------------------------------------------------
       John C. Lawrence, President
Principal Executive Officer


By: /s/John C. Lawrence
   --------------------------------------------------
   John C. Lawrence, Chief Financial Officer, Secretary, Treasurer and Director
Principal Accounting Officer and Principal Financial Officer


         THE PLAN: Pursuant to the requirements of the Securities Act of 1933,
the Board of Directors who administer the 2004 Directors, Officers and
Consultants Stock Option, Stock Warrant and Stock Award Plan have duly caused
this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Thompson Falls, Montana on the 12th day of July,
2004.



/s/John C. Lawrence, Director                   /s/Robert A. Rice, Director



/s/Leo Jackson, Director




                                   EXHIBIT 4.1

                          United States Antimony Corp.
                    2004 DIRECTORS, OFFICERS AND CONSULTANTS
                STOCK OPTION, STOCK WARRANT AND STOCK AWARD PLAN

SECTION 1. PURPOSE OF THE PLAN. The purpose of the 2004 Directors, Officers and
Consultants Stock Option, Stock Warrant and Stock Award Plan ("Plan") is to
maintain the ability of United States Antimony Corp., a Montana corporation (the
"Company") and its subsidiaries to attract and retain highly qualified and
experienced directors, employees and consultants and to give such directors,
employees and consultants a continued proprietary interest in the success of the
Company and its subsidiaries. In addition the Plan is intended to encourage
ownership of common stock, $.001 par value ("Common Stock"), of the Company by
the directors, employees and consultants of the Company and its Affiliates (as
defined below) and to provide increased incentive for such persons to render
services and to exert maximum effort for the success of the Company's business.
The Plan provides eligible employees and consultants the opportunity to
participate in the enhancement of shareholder value by the grants of warrants,
options, restricted common or convertible preferred stock, unrestricted common
or convertible preferred stock and other awards under this Plan and to have
their bonuses and/or consulting fees payable in warrants, restricted common or
convertible preferred stock, unrestricted common or convertible preferred stock
and other awards, or any combination thereof. In addition, the Company expects
that the Plan will further strengthen the identification of the directors,
employees and consultants with the stockholders. Certain options and warrants to
be granted under this Plan are intended to qualify as Incentive Stock Options
("ISOs") pursuant to Section 422 of the Internal Revenue Code of 1986, as
amended ("Code"), while other options and warrants and preferred stock granted
under this Plan will be nonqualified options or warrants which are not intended
to qualify as ISOs ("Nonqualified Options"), either or both as provided in the
agreements evidencing the options or warrants described in Section 5 hereof and
shares of preferred stock. As provided in the designation described in Section
7. Employees, consultants and directors who participate or become eligible to
participate in this Plan from time to time are referred to collectively herein
as "Participants". As used in this Plan, the term "Affiliates" means any "parent
corporation" of the Company and any "subsidiary corporation" of the Company
within the meaning of Code Sections 424(e) and (f), respectively.

SECTION 2.  ADMINISTRATION OF THE PLAN.

         (a) Composition of Committee. The Plan shall be administered by the
Board of Directors of the Company (the "Board"). When acting in such capacity
the Board is herein referred to as the "Committee," which shall also designate
the Chairman of the Committee. If the Company is governed by Rule 16b-3
promulgated by the Securities and Exchange Commission ("Commission") pursuant to
the Securities Exchange Act of 1934, as amended ("Exchange Act"), no director
shall serve as a member of the Committee unless he or she is a "disinterested
person" within the meaning of such Rule 16b-3.

         (b) Committee Action. The Committee shall hold its meetings at such
times and places as it may determine. A majority of its members shall constitute
a quorum, and all determinations of the Committee shall be made by not less than
a majority of its members. Any decision or determination reduced to writing and
signed by a majority of the members shall be fully as effective as if it had
been made by a majority vote of its members at a meeting duly called and held.
The Committee may designate the Secretary of the Company or other Company
employees to assist the Committee in the administration of the Plan, and may
grant authority to such persons to execute award agreements or other documents
on behalf of the Committee and the Company. Any duly constituted committee of
the Board satisfying the qualifications of this Section 2 may be appointed as
the Committee.

         (c) Committee Expenses. All expenses and liabilities incurred by the
Committee in the administration of the Plan shall be borne by the Company. The
Committee may employ attorneys, consultants, accountants or other persons.

SECTION 3. STOCK RESERVED FOR THE PLAN. Subject to adjustment as provided in
Section 5(d)(xiii) hereof, the aggregate number of shares that may be optioned,
subject to conversion or issued under the Plan is 400,000 shares of Common
Stock, warrants, options, preferred stock or any combination thereof. The shares
subject to the Plan shall consist of authorized but unissued shares of Common
Stock and such number of shares shall be and is hereby reserved for sale for
such purpose. Any of such shares which may remain unsold and which are not
subject to issuance upon exercise of outstanding options or warrants or
conversion of outstanding shares of preferred stock at the termination of the
Plan shall cease to be reserved for the purpose of the Plan, but until
termination of the Plan or the termination of the last of the options or
warrants granted under the Plan, whichever last occurs, the Company shall at all
times reserve a sufficient number of shares to meet the requirements of the
Plan. Should any option or warrant expire or be cancelled prior to its exercise
in full, the shares theretofore subject to such option or warrant may again be
made subject to an option, warrant or shares of convertible preferred stock
under the Plan.

SECTION 4. ELIGIBILITY. The Participants shall include directors, employees,
including officers, of the Company and its divisions and subsidiaries, and
consultants and attorneys who provide bona fide services to the Company.
Participants are eligible to be granted warrants, options, restricted common or
convertible preferred stock, unrestricted common or convertible preferred stock
and other awards under this Plan and to have their bonuses and/or consulting
fees payable in warrants, restricted common or convertible preferred stock,
unrestricted common or convertible preferred stock and other awards. A
Participant who has been granted an option, warrant or preferred stock hereunder
may be granted an additional option, warrant options, warrants or preferred
stock, if the Committee shall so determine.

SECTION 5.  GRANT OF OPTIONS OR WARRANTS.

         (a) Committee Discretion. The Committee shall have sole and absolute
discretionary authority (i) to determine, authorize, and designate those persons
pursuant to this Plan who are to receive warrants, options, restricted common or
convertible preferred stock, or unrestricted common or convertible preferred
stock under the Plan, (ii) to determine the number of shares of Common Stock to
be covered by such grant or such options or warrants and the terms thereof,
(iii) to determine the type of Common Stock granted: restricted common or
convertible preferred stock, unrestricted common or convertible preferred stock
or a combination of restricted and unrestricted common or convertible preferred
stock, and (iv) to determine the type of option or warrant granted: ISO,
Nonqualified Option or a combination of ISO and Nonqualified Options. The
Committee shall thereupon grant options or warrants in accordance with such
determinations as evidenced by a written option or warrant agreement. Subject to
the express provisions of the Plan, the Committee shall have discretionary
authority to prescribe, amend and rescind rules and regulations relating to the
Plan, to interpret the Plan, to prescribe and amend the terms of the option or
warrant agreements (which need not be identical) and to make all other
determinations deemed necessary or advisable for the administration of the Plan.

         (b) Stockholder Approval. All ISOs granted under this Plan are subject
to, and may not be exercised before, the approval of this Plan by the
stockholders prior to the first anniversary date of the Board meeting held to
approve the Plan, by the affirmative vote of the holders of a majority of the
outstanding shares of the Company present, or represented by proxy, and entitled
to vote thereat, or by written consent in accordance with the laws of the State
of Montana, provided that if such approval by the stockholders of the Company is
not forthcoming, all options or warrants and stock awards previously granted
under this Plan other than ISOs shall be valid in all respects.

         (c) Limitation on Incentive Stock Options and Warrants. The aggregate
fair market value (determined in accordance with Section 5(d)(ii) of this Plan
at the time the option or warrant is granted) of the Common Stock with respect
to which ISOs may be exercisable for the first time by any Participant during
any calendar year under all such plans of the Company and its Affiliates shall
not exceed $3,000,000.

         (d) Terms and Conditions. Each option or warrant granted under the Plan
shall be evidenced by an agreement, in a form approved by the Committee, which
shall be subject to the following express terms and conditions and to such other
terms and conditions as the Committee may deem appropriate:

                  (i) Option or Warrant Period. The Committee shall promptly
         notify the Participant of the option or warrant grant and a written
         agreement shall promptly be executed and delivered by and on behalf of
         the Company and the Participant, provided that the option or warrant
         grant shall expire if a written agreement is not signed by said
         Participant (or his agent or attorney) and returned to the Company
         within 60 days from date of receipt by the Participant of such
         agreement. The date of grant shall be the date the option or warrant is
         actually granted by the Committee, even though the written agreement
         may be executed and delivered by the Company and the Participant after
         that date. Each option or warrant agreement shall specify the period
         for which the option or warrant thereunder is granted (which in no
         event shall exceed ten years from the date of grant) and shall provide
         that the option or warrant shall expire at the end of such period. If
         the original term of an option or warrant is less than ten years from
         the date of grant, the option or warrant may be amended prior to its
         expiration, with the approval of the Committee and the Participant, to
         extend the term so that the term as amended is not more than ten years
         from the date of grant. However, in the case of an ISO granted to an
         individual who, at the time of grant, owns stock possessing more than
         10 percent of the total combined voting power of all classes of stock
         of the Company or its Affiliate ("Ten Percent Stockholder"), such
         period shall not exceed five years from the date of grant.

                  (ii) Option or Warrant Price. The purchase price of each share
         of Common Stock subject to each option or warrant granted pursuant to
         the Plan shall be determined by the Committee at the time the option or
         warrant is granted and, in the case of ISOs, shall not be less than
         100% of the fair market value of a share of Common Stock on the date
         the option or warrant is granted, as determined by the Committee. In
         the case of an ISO granted to a Ten Percent Stockholder, the option or
         warrant price shall not be less than 110% of the fair market value of a
         share of Common Stock on the date the option or warrant is granted. The
         purchase price of each share of Common Stock subject to a Nonqualified
         Option or Warrant under this Plan shall be determined by the Committee
         prior to granting the option or warrant. The Committee shall set the
         purchase price for each share subject to a Nonqualified Option or
         Warrant at either the fair market value of each share on the date the
         option or warrant is granted, or at such other price as the Committee
         in its sole discretion shall determine.

                  At the time a determination of the fair market value of a
         share of Common Stock is required to be made hereunder, the
         determination of its fair market value shall be made by the Committee
         in such manner as it deems appropriate.

                  (iii) Exercise Period. The Committee may provide in the option
         or warrant agreement that an option or warrant may be exercised in
         whole, immediately, or is to be exercisable in increments. In addition,
         the Committee may provide that the exercise of all or part of an option
         or warrant is subject to specified performance by the Participant.

                  (iv) Procedure for Exercise. Options or warrants shall be
         exercised in the manner specified in the option or warrant agreement.
         The notice of exercise shall specify the address to which the
         certificates for such shares are to be mailed. A Participant shall be
         deemed to be a stockholder with respect to shares covered by an option
         or warrant on the date specified in the option or warrant agreement .
         As promptly as practicable, the Company shall deliver to the
         Participant or other holder of the warrant, certificates for the number
         of shares with respect to which such option or warrant has been so
         exercised, issued in the holder's name or such other name as holder
         directs; provided, however, that such delivery shall be deemed effected
         for all purposes when a stock transfer agent of the Company shall have
         deposited such certificates with a carrier for overnight delivery,
         addressed to the holder at the address specified pursuant to this
         Section 6(d).

                  (v) Termination of Employment. If an executive officer to whom
         an option or warrant is granted ceases to be employed by the Company
         for any reason other than death or disability, any option or warrant
         which is exercisable on the date of such termination of employment may
         be exercised during a period beginning on such date and ending at the
         time set forth in the option or warrant agreement; provided, however,
         that if a Participant's employment is terminated because of the
         Participant's theft or embezzlement from the Company, disclosure of
         trade secrets of the Company or the commission of a willful, felonious
         act while in the employment of the Company (such reasons shall
         hereinafter be collectively referred to as "for cause"), then any
         option or warrant or unexercised portion thereof granted to said
         Participant shall expire upon such termination of employment.
         Notwithstanding the foregoing, no ISO may be exercised later than three
         months after an employee's termination of employment for any reason
         other than death or disability.

                  (vi) Disability or Death of Participant. In the event of the
         determination of disability or death of a Participant under the Plan
         while he or she is employed by the Company, the options or warrants
         previously granted to him may be exercised (to the extent he or she
         would have been entitled to do so at the date of the determination of
         disability or death) at any time and from time to time, within a period
         beginning on the date of such determination of disability or death and
         ending at the time set forth in the option or warrant agreement, by the
         former employee, the guardian of his estate, the executor or
         administrator of his estate or by the person or persons to whom his
         rights under the option or warrant shall pass by will or the laws of
         descent and distribution, but in no event may the option or warrant be
         exercised after its expiration under the terms of the option or warrant
         agreement. Notwithstanding the foregoing, no ISO may be exercised later
         than one year after the determination of disability or death. A
         Participant shall be deemed to be disabled if, in the opinion of a
         physician selected by the Committee, he or she is incapable of
         performing services for the Company of the kind he or she was
         performing at the time the disability occurred by reason of any
         medically determinable physical or mental impairment which can be
         expected to result in death or to be of long, continued and indefinite
         duration. The date of determination of disability for purposes hereof
         shall be the date of such determination by such physician.

                  (vii) Assignability. An option or warrant shall be assignable
         or otherwise transferable, in whole or in part, by a Participant as
         provided in the option, warrant or designation of the series of
         preferred stock.

                  (viii) Incentive Stock Options. Each option or warrant
         agreement may contain such terms and provisions as the Committee may
         determine to be necessary or desirable in order to qualify an option or
         warrant designated as an incentive stock option.

                  (ix) Restricted Stock Awards. Awards of restricted stock under
         this Plan shall be subject to all the applicable provisions of this
         Plan, including the following terms and conditions, and to such other
         terms and conditions not inconsistent therewith, as the Committee shall
         determine:

                           (A) Awards of restricted stock may be in addition to
                  or in lieu of option or warrant grants. Awards may be
                  conditioned on the attainment of particular performance goals
                  based on criteria established by the Committee at the time of
                  each award of restricted stock. During a period set forth in
                  the agreement (the "Restriction Period"), the recipient shall
                  not be permitted to sell, transfer, pledge, or otherwise
                  encumber the shares of restricted stock; except that such
                  shares may be used, if the agreement permits, to pay the
                  option or warrant price pursuant to any option or warrant
                  granted under this Plan, provided an equal number of shares
                  delivered to the Participant shall carry the same restrictions
                  as the shares so used. Shares of restricted stock shall become
                  free of all restrictions if during the Restriction Period, (i)
                  the recipient dies, (ii) the recipient's directorship,
                  employment, or consultancy terminates by reason of permanent
                  disability, as determined by the Committee, (iii) the
                  recipient retires after attaining both 59 1/2 years of age and
                  five years of continuous service with the Company and/or a
                  division or subsidiary, or (iv) if provided in the agreement,
                  there is a "change in control" of the Company (as defined in
                  such agreement). The Committee may require medical evidence of
                  permanent disability, including medical examinations by
                  physicians selected by it. Unless and to the extent otherwise
                  provided in the agreement, shares of restricted stock shall be
                  forfeited and revert to the Company upon the recipient's
                  termination of directorship, employment or consultancy during
                  the Restriction Period for any reason other than death,
                  permanent disability, as determined by the Committee,
                  retirement after attaining both 59 1/2 years of age and five
                  years of continuous service with the Company and/or a
                  subsidiary or division, or, to the extent provided in the
                  agreement, a "change in control" of the Company (as defined in
                  such agreement), except to the extent the Committee, in its
                  sole discretion, finds that such forfeiture might not be in
                  the best interests of the Company and, therefore, waives all
                  or part of the application of this provision to the restricted
                  stock held by such recipient. Certificates for restricted
                  stock shall be registered in the name of the recipient but
                  shall be imprinted with the appropriate legend and returned to
                  the Company by the recipient, together with a stock power
                  endorsed in blank by the recipient. The recipient shall be
                  entitled to vote shares of restricted stock and shall be
                  entitled to all dividends paid thereon, except that dividends
                  paid in Common Stock or other property shall also be subject
                  to the same restrictions.

                           (B) Restricted Stock shall become free of the
                  foregoing restrictions upon expiration of the applicable
                  Restriction Period and the Company shall then deliver to the
                  recipient Common Stock certificates evidencing such stock.
                  Restricted stock and any Common Stock received upon the
                  expiration of the restriction period shall be subject to such
                  other transfer restrictions and/or legend requirements as are
                  specified in the applicable agreement.

                  (x) Bonuses and Past Salaries and Fees Payable in Unrestricted
Stock.

                           (A) In lieu of cash bonuses otherwise payable under
                  the Company's or applicable division's or subsidiary's
                  compensation practices to employees and consultants eligible
                  to participate in this Plan, the Committee, in its sole
                  discretion, may determine that such bonuses shall be payable
                  in unrestricted Common Stock or partly in unrestricted Common
                  Stock and partly in cash. Such bonuses shall be in
                  consideration of services previously performed and as an
                  incentive toward future services and shall consist of shares
                  of unrestricted Common Stock subject to such terms as the
                  Committee may determine in its sole discretion. The number of
                  shares of unrestricted Common Stock payable in lieu of a bonus
                  otherwise payable shall be determined by dividing such bonus
                  amount by the fair market value of one share of Common Stock
                  on the date the bonus is payable, with fair market value
                  determined as of such date in accordance with Section
                  5(d)(ii).

                           (B) In lieu of salaries and fees otherwise payable by
                  the Company to employees, attorneys and consultants eligible
                  to participate in this Plan that were incurred for services
                  rendered during, prior or after the year of 2004, the
                  Committee, in its sole discretion, may determine that such
                  unpaid salaries and fees shall be payable in unrestricted
                  Common Stock or partly in unrestricted Common Stock and partly
                  in cash. Such awards shall be in consideration of services
                  previously performed and as an incentive toward future
                  services and shall consist of shares of unrestricted Common
                  Stock subject to such terms as the Committee may determine in
                  its sole discretion. The number of shares of unrestricted
                  Common Stock payable in lieu of a salaries and fees otherwise
                  payable shall be determined by dividing each calendar month's
                  of unpaid salary or fee amount by the average trading value of
                  the Common Stock for the calendar month during which the
                  subject services were provided.

                  (xi) No Rights as Stockholder. No Participant shall have any
         rights as a stockholder with respect to shares covered by an option or
         warrant until the option or warrant is exercised as provided in clause
         (d) above.

                  (xii) Extraordinary Corporate Transactions. The existence of
         outstanding options or warrants shall not affect in any way the right
         or power of the Company or its stockholders to make or authorize any or
         all adjustments, recapitalizations, reorganizations, exchanges, or
         other changes in the Company's capital structure or its business, or
         any merger or consolidation of the Company, or any issuance of Common
         Stock or other securities or subscription rights thereto, or any
         issuance of bonds, debentures, preferred or prior preference stock
         ahead of or affecting the Common Stock or the rights thereof, or the
         dissolution or liquidation of the Company, or any sale or transfer of
         all or any part of its assets or business, or any other corporate act
         or proceeding, whether of a similar character or otherwise. If the
         Company recapitalizes or otherwise changes its capital structure, or
         merges, consolidates, sells all of its assets or dissolves (each of the
         foregoing a "Fundamental Change"), then thereafter upon any exercise of
         an option or warrant theretofore granted the Participant shall be
         entitled to purchase under such option or warrant, in lieu of the
         number of shares of Common Stock as to which option or warrant shall
         then be exercisable, the number and class of shares of stock and
         securities to which the Participant would have been entitled pursuant
         to the terms of the Fundamental Change if, immediately prior to such
         Fundamental Change, the Participant had been the holder of record of
         the number of shares of Common Stock as to which such option or warrant
         is then exercisable. If (i) the Company shall not be the surviving
         entity in any merger or consolidation (or survives only as a subsidiary
         of another entity), (ii) the Company sells all or substantially all of
         its assets to any other person or entity (other than a wholly-owned
         subsidiary), (iii) any person or entity (including a "group" as
         contemplated by Section 13(d)(3) of the Exchange Act) acquires or gains
         ownership or control of (including, without limitation, power to vote)
         more than 50% of the outstanding shares of Common Stock, (iv) the
         Company is to be dissolved and liquidated, or (v) as a result of or in
         connection with a contested election of directors, the persons who were
         directors of the Company before such election shall cease to constitute
         a majority of the Board (each such event in clauses (i) through (v)
         above is referred to herein as a "Corporate Change"), the Committee, in
         its sole discretion, may accelerate the time at which all or a portion
         of a Participant's option or warrants may be exercised for a limited
         period of time before or after a specified date.

                  (xiii) Changes in Company's Capital Structure. If the
         outstanding shares of Common Stock or other securities of the Company,
         or both, for which the option or warrant is then exercisable at any
         time be changed or exchanged by declaration of a stock dividend, stock
         split, combination of shares, recapitalization, or reorganization, the
         number and kind of shares of Common Stock or other securities which are
         subject to the Plan or subject to any options or warrants theretofore
         granted, and the option or warrant prices, shall be adjusted only as
         provided in the option or warrant.

                  (xiv) Acceleration of Options and Warrants. Except as
         hereinbefore expressly provided, (i) the issuance by the Company of
         shares of stock or any class of securities convertible into shares of
         stock of any class, for cash, property, labor or services, upon direct
         sale, upon the exercise of rights or warrants to subscribe therefor, or
         upon conversion of shares or obligations of the Company convertible
         into such shares or other securities, (ii) the payment of a dividend in
         property other than Common Stock or (iii) the occurrence of any similar
         transaction, and in any case whether or not for fair value, shall not
         affect, and no adjustment by reason thereof shall be made with respect
         to, the number of shares of Common Stock subject to options or warrants
         theretofore granted or the purchase price per share, unless the
         Committee shall determine, in its sole discretion, that an adjustment
         is necessary to provide equitable treatment to Participant.
         Notwithstanding anything to the contrary contained in this Plan, the
         Committee may, in its sole discretion, accelerate the time at which any
         option or warrant may be exercised, including, but not limited to, upon
         the occurrence of the events specified in this Section 5, and is
         authorized at any time (with the consent of the Participant) to
         purchase options or warrants pursuant to Section 6.

SECTION 6.  RELINQUISHMENT OF OPTIONS OR WARRANTS.

         (a) The Committee, in granting options or warrants hereunder, shall
have discretion to determine whether or not options or warrants shall include a
right of relinquishment as hereinafter provided by this Section 6. The Committee
shall also have discretion to determine whether an option or warrant agreement
evidencing an option or warrant initially granted by the Committee without a
right of relinquishment shall be amended or supplemented to include such a right
of relinquishment. Neither the Committee nor the Company shall be under any
obligation or incur any liability to any person by reason of the Committee's
refusal to grant or include a right of relinquishment in any option or warrant
granted hereunder or in any option or warrant agreement evidencing the same.
Subject to the Committee's determination in any case that the grant by it of a
right of relinquishment is consistent with Section 1 hereof, any option or
warrant granted under this Plan, and the option or warrant agreement evidencing
such option or warrant, may provide:

                  (i) That the Participant, or his or her heirs or other legal
         representatives to the extent entitled to exercise the option or
         warrant under the terms thereof, in lieu of purchasing the entire
         number of shares subject to purchase thereunder, shall have the right
         to relinquish all or any part of the then unexercised portion of the
         option or warrant (to the extent then exercisable) for a number of
         shares of Common Stock to be determined in accordance with the
         following provisions of this clause (i):

                           (A) The written notice of exercise of such right of
                  relinquishment shall state the percentage of the total number
                  of shares of Common Stock issuable pursuant to such
                  relinquishment (as defined below) that the Participant elects
                  to receive;

                           (B) The number of shares of Common Stock, if any,
                  issuable pursuant to such relinquishment shall be the number
                  of such shares, rounded to the next greater number of full
                  shares, as shall be equal to the quotient obtained by dividing
                  (i) the Appreciated Value by (ii) the purchase price for each
                  of such shares specified in such option or warrant;

                           (C) For the purpose of this clause (C), "Appreciated
                  Value" means the excess, if any, of (x) the total current
                  market value of the shares of Common Stock covered by the
                  option or warrant or the portion thereof to be relinquished
                  over (y) the total purchase price for such shares specified in
                  such option or warrant;

                  (ii) That such right of relinquishment may be exercised only
         upon receipt by the Company of a written notice of such relinquishment
         which shall be dated the date of election to make such relinquishment;
         and that, for the purposes of this Plan, such date of election shall be
         deemed to be the date when such notice is sent by registered or
         certified mail, or when receipt is acknowledged by the Company, if
         mailed by other than registered or certified mail or if delivered by
         hand or by any telegraphic communications equipment of the sender or
         otherwise delivered; provided, that, in the event the method just
         described for determining such date of election shall not be or remain
         consistent with the provisions of Section 16(b) of the Exchange Act or
         the rules and regulations adopted by the Commission thereunder, as
         presently existing or as may be hereafter amended, which regulations
         exempt from the operation of Section 16(b) of the Exchange Act in whole
         or in part any such relinquishment transaction, then such date of
         election shall be determined by such other method consistent with
         Section 16(b) of the Exchange Act or the rules and regulations
         thereunder as the Committee shall in its discretion select and apply;

                  (iii) That the "current market value" of a share of Common
         Stock on a particular date shall be deemed to be its fair market value
         on that date as determined in accordance with Paragraph 5(d)(ii); and

                  (iv) That the option or warrant, or any portion thereof, may
         be relinquished only to the extent that (A) it is exercisable on the
         date written notice of relinquishment is received by the Company, and
         (B) the holder of such option or warrant pays, or makes provision
         satisfactory to the Company for the payment of, any taxes which the
         Company is obligated to collect with respect to such relinquishment.

         (b) The Committee shall have sole discretion to consent to or
disapprove, and neither the Committee nor the Company shall be under any
liability by reason of the Committee's disapproval of, any election by a holder
of preferred stock to relinquish such preferred stock in whole or in part as
provided in Paragraph 7(a), except that no such consent to or approval of a
relinquishment shall be required under the following circumstances. Each
Participant who is subject to the short-swing profits recapture provisions of
Section 16(b) of the Exchange Act ("Covered Participant") shall not be entitled
to receive shares of Common Stock when options or warrants are relinquished
during any window period commencing on the third business day following the
Company's release of a quarterly or annual summary statement of sales and
earnings and ending on the twelfth business day following such release ("Window
Period"). A Covered Participant shall be entitled to receive shares of Common
Stock upon the relinquishment of options or warrants outside a Window Period.

         (c) The Committee, in granting options or warrants hereunder, shall
have discretion to determine the terms upon which such options or warrants shall
be relinquishable, subject to the applicable provisions of this Plan, and
including such provisions as are deemed advisable to permit the exemption from
the operation from Section 16(b) of the Exchange Act of any such relinquishment
transaction, and options or warrants outstanding, and option agreements
evidencing such options, may be amended, if necessary, to permit such exemption.
If options or warrants are relinquished, such option or warrant shall be deemed
to have been exercised to the extent of the number of shares of Common Stock
covered by the option or warrant or part thereof which is relinquished, and no
further options or warrants may be granted covering such shares of Common Stock.

         (d) Any options or warrants or any right to relinquish the same to the
Company as contemplated by this Paragraph 6 shall be assignable by the
Participant, provided the transaction complies with any applicable securities
laws.

         (e) Except as provided in Section 6(f) below, no right of
relinquishment may be exercised within the first six months after the initial
award of any option or warrant containing, or the amendment or supplementation
of any existing option or warrant agreement adding, the right of relinquishment.

         (f) No right of relinquishment may be exercised after the initial award
of any option or warrant containing, or the amendment or supplementation of any
existing option or warrant agreement adding the right of relinquishment, unless
such right of relinquishment is effective upon the Participant's death,
disability or termination of his relationship with the Company for a reason
other than "for cause."

SECTION 7. AMENDMENTS OR TERMINATION. The Board may amend, alter or discontinue
the Plan, but no amendment or alteration shall be made which would impair the
rights of any Participant, without his consent, under any option, warrant or
preferred stock theretofore granted.

SECTION 8. COMPLIANCE WITH OTHER LAWS AND REGULATIONS. The Plan, the grant and
exercise of options or warrants and grant and conversion of preferred stock
thereunder, and the obligation of the Company to sell and deliver shares under
such options, warrants or preferred stock, shall be subject to all applicable
federal and state laws, rules and regulations and to such approvals by any
governmental or regulatory agency as may be required. The Company shall not be
required to issue or deliver any certificates for shares of Common Stock prior
to the completion of any registration or qualification of such shares under any
federal or state law or issuance of any ruling or regulation of any government
body which the Company shall, in its sole discretion, determine to be necessary
or advisable. Any adjustments provided for in subparagraphs 5(d)(xii), (xiii)
and (xiv) shall be subject to any shareholder action required by the corporate
law of the state of incorporation of the Company.

SECTION 9. PURCHASE FOR INVESTMENT. Unless the options, warrants, shares of
convertible preferred stock and shares of Common Stock covered by this Plan have
been registered under the Securities Act of 1933, as amended, or the Company has
determined that such registration is unnecessary, each person acquiring or
exercising an option or warrant under this Plan or converting shares of
preferred stock may be required by the Company to give a representation in
writing that he or she is acquiring such option or warrant or such shares for
his own account for investment and not with a view to, or for sale in connection
with, the distribution of any part thereof.

SECTION 10.  TAXES.

         (a) The Company may make such provisions as it may deem appropriate for
the withholding of any taxes which it determines is required in connection with
any options, warrants or preferred stock granted under this Plan.

         (b) Notwithstanding the terms of Paragraph 10 (a), any Participant may
pay all or any portion of the taxes required to be withheld by the Company or
paid by him or her in connection with the exercise of a nonqualified option or
warrant or conversion of preferred stock by electing to have the Company
withhold shares of Common Stock, or by delivering previously owned shares of
Common Stock, having a fair market value, determined in accordance with
Paragraph 5(d)(ii), equal to the amount required to be withheld or paid. A
Participant must make the foregoing election on or before the date that the
amount of tax to be withheld is determined ("Tax Date"). All such elections are
irrevocable and subject to disapproval by the Committee. Elections by Covered
Participants are subject to the following additional restrictions: (i) such
election may not be made within six months of the grant of an option or warrant,
provided that this limitation shall not apply in the event of death or
disability, and (ii) such election must be made either six months or more prior
to the Tax Date or in a Window Period. Where the Tax Date in respect of an
option or warrant is deferred until six months after exercise and the Covered
Participant elects share withholding, the full amount of shares of Common Stock
will be issued or transferred to him upon exercise of the option or warrant, but
he or she shall be unconditionally obligated to tender back to the Company the
number of shares necessary to discharge the Company's withholding obligation or
his estimated tax obligation on the Tax Date.

SECTION 11. REPLACEMENT OF OPTIONS, WARRANTS AND PREFERRED STOCK. The Committee
from time to time may permit a Participant under the Plan to surrender for
cancellation any unexercised outstanding option or warrant or unconverted
Preferred stock and receive from the Company in exchange an option, warrant or
preferred stock for such number of shares of Common Stock as may be designated
by the Committee. The Committee may, with the consent of the holder of any
outstanding option, warrant or preferred stock, amend such option, warrant or
preferred stock, including reducing the exercise price of any option or warrant
to not less than the fair market value of the Common Stock at the time of the
amendment, increasing the conversion ratio of any preferred stock and extending
the exercise or conversion term of and warrant, option or preferred stock.

SECTION 12. NO RIGHT TO COMPANY EMPLOYMENT. Nothing in this Plan or as a result
of any option or warrant granted pursuant to this Plan shall confer on any
individual any right to continue in the employ of the Company or interfere in
any way with the right of the Company to terminate an individual's employment at
any time. The option, warrant or preferred stock agreements may contain such
provisions as the Committee may approve with reference to the effect of approved
leaves of absence.

SECTION 13. LIABILITY OF COMPANY. The Company and any Affiliate which is in
existence or hereafter comes into existence shall not be liable to a Participant
or other persons as to:

         (a) The Non-Issuance of Shares. The non-issuance or sale of shares as
to which the Company has been unable to obtain from any regulatory body having
jurisdiction the authority deemed by the Company's counsel to be necessary to
the lawful issuance and sale of any shares hereunder; and

         (b) Tax Consequences. Any tax consequence expected, but not realized,
by any Participant or other person due to the exercise of any option or warrant
or the conversion of any preferred stock granted hereunder.

SECTION 14. EFFECTIVENESS AND EXPIRATION OF PLAN. The Plan shall be effective on
the date the Board adopts the Plan. The Plan shall expire ten years after the
date the Board approves the Plan and thereafter no option, warrant or preferred
stock shall be granted pursuant to the Plan.

SECTION 15. NON-EXCLUSIVITY OF THE PLAN. Neither the adoption by the Board nor
the submission of the Plan to the stockholders of the Company for approval shall
be construed as creating any limitations on the power of the Board to adopt such
other incentive arrangements as it may deem desirable, including without
limitation, the granting of restricted stock or stock options, warrants or
preferred stock otherwise than under the Plan, and such arrangements may be
either generally applicable or applicable only in specific cases.

SECTION 16. GOVERNING LAW. This Plan and any agreements hereunder shall be
interpreted and construed in accordance with the laws of the state of
incorporation of the Company and applicable federal law.

SECTION 174. CASHLESS EXERCISE. The Committee also may allow cashless exercises
as permitted under Federal Reserve Board's Regulation T, subject to applicable
securities law restrictions. or by any other means which the Committee
determines to be consistent with the Plan's purpose and applicable law. The
proceeds from such a payment shall be added to the general funds of the Company
and shall be used for general corporate purposes.




                                EXHIBIT 5 & 24.1
                              SONFIELD AND SONFIELD
                       770 SOUTH POST OAK LANE, SUITE 435
                              HOUSTON, TEXAS 77056
                                TEL 713-877-8333
                                FAX 713-877-1547
                              ROBERT@SONFIELD.COM
                                WWW.SONFIELD.COM

                                  July 27, 2004
Board of Directors
United States Antimony Corp.
P.O. Box 643 Thompson Falls, Montana 59873

Ladies and Gentlemen:

         In our capacity as counsel for United States Antimony Corp., a Montana
corporation (the "Company"), we have participated in the corporate proceedings
relative to the authorization and issuance by the Company of a maximum of
400,000 shares of common stock pursuant to the Plan as set out and described in
the Company's Registration Statement on Form S-8 (File No. 001-08675) under the
Securities Act of 1933 (the "Registration Statement"). We have also participated
in the preparation and filing of the Registration Statement.

         Based upon the foregoing and upon our examination of originals (or
copies certified to our satisfaction) of such corporate records of the Company
and other documents as we have deemed necessary as a basis for the opinions
hereinafter expressed, and assuming the accuracy and completeness of all
information supplied us by the Company, having regard for the legal
considerations which we deem relevant, we are of the opinion that:

                  (1)      The Company is a corporation duly organized and
         validly existing under the laws of the State of Montana;

                  (2) The Company has taken all requisite corporate action and
         all action required by the laws of the State of Montana with respect to
         the authorization, issuance and sale of warrants and shares of common
         and preferred stock to be issued pursuant to the Registration
         Statement; and

                  (3) The 400,000 shares of common stock, when issued pursuant
         to the Registration Statement, will be validly issued, fully paid and
         non-assessable; and

         We hereby consent to the use of this opinion as an exhibit to the
Registration Statement and to the references to our firm in the Registration
Statement.

Yours very truly,


/s/SONFIELD & SONFIELD
SONFIELD & SONFIELD


                                  EXHIBIT 24.2


               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS




         We consent to the inclusion in this Form S-8 of United States Antimony
Corp. of our report dated February 13, 2004, on our audit of the financial
statements of United States Antimony Corp. as of December 31, 2003, and the
related consolidated statements of operations, stockholders' deficit and cash
flows for the years ended December 31, 2003 and 2002.



/s/DeCoria, Maichel & Teague P.S.

Spokane, Washington
July 27, 2004